90
Participants
Start Date
June 30, 2005
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
DR-2001a
DR-2001a administered vaginally each month
DR-2001b
DR-2001b administered vaginally each month
Placebo
Placebo administered vaginally each month
Duramed Investigational Site, Port Jefferson
Duramed Investigational Site, Virginia Beach
Duramed Investigational Site, Norfolk
Duramed Investigational Site, Winston-Salem
Duramed Investigational Site, Chapel Hill
Duramed Investigational Site, Morganton
Duramed Investigational Site, Florence
Duramed Investigational Site, Decatur
Duramed Investigational Site, West Palm Beach
Duramed Investigational Site, Tampa
Duramed Investigational Site, Clearwater
Duramed Investigational Site, Spring Hill
Duramed Investigational Site, Hudson
Duramed Investigational Site, Jenkintown
Duramed Investigational Site, Enterprise
Duramed Investigational Site, Memphis
Duramed Investigational Site, Jackson
Duramed Investigational Site, Louisville
Duramed Investigational Site, Columbus
Duramed Investigational Site, Dayton
Duramed Investigational Site, Ann Arbor
Duramed Investigational Site, Montgomery
Duramed Investigational Site, Maywood
Duramed Investigational Site, Oak Brook
Duramed Investigational Site, La Grange Park
Duramed Investigational Site, Little Rock
Duramed Investigational Site, Oklahoma City
Duramed Investigational Site, Dallas
Duramed Investigational Site, San Antonio
Duramed Investigational Site, Austin
Duramed Investigational Site, Colorado Springs
Duramed Investigational Site, Idaho Falls
Duramed Investigational Site, Pleasant Grove
Duramed Investigational Site, Sandy City
Duramed Investigational Site, Phoenix
Duramed Investigational Site, Tucson
Duramed Investigational Site, Reno
Duramed Investigational Site, Vista
Duramed Investigational Site, La Jolla
Duramed Investigational Site, San Diego
Duramed Investigational Site, Princeton
Lead Sponsor
Duramed Research
INDUSTRY